Vanguard Group
CPRX icon

Vanguard Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$190M Buy
8,765,835
+270,255
+3% +$5.86M ﹤0.01% 1523
2025
Q1
$206M Buy
8,495,580
+64,486
+0.8% +$1.56M ﹤0.01% 1467
2024
Q4
$176M Buy
8,431,094
+390,116
+5% +$8.14M ﹤0.01% 1601
2024
Q3
$160M Sell
8,040,978
-59,377
-0.7% -$1.18M ﹤0.01% 1656
2024
Q2
$125M Buy
8,100,355
+119,694
+1% +$1.85M ﹤0.01% 1732
2024
Q1
$127M Buy
7,980,661
+860,244
+12% +$13.7M ﹤0.01% 1741
2023
Q4
$120M Buy
7,120,417
+73,930
+1% +$1.24M ﹤0.01% 1767
2023
Q3
$82.4M Buy
7,046,487
+174,739
+3% +$2.04M ﹤0.01% 1910
2023
Q2
$92.4M Sell
6,871,748
-54,698
-0.8% -$735K ﹤0.01% 1893
2023
Q1
$115M Buy
6,926,446
+157,705
+2% +$2.61M ﹤0.01% 1764
2022
Q4
$126M Buy
6,768,741
+629,091
+10% +$11.7M ﹤0.01% 1675
2022
Q3
$78.8M Buy
6,139,650
+1,277,662
+26% +$16.4M ﹤0.01% 1936
2022
Q2
$34.1M Buy
4,861,988
+128,384
+3% +$900K ﹤0.01% 2380
2022
Q1
$39.2M Sell
4,733,604
-102,709
-2% -$851K ﹤0.01% 2422
2021
Q4
$32.7M Sell
4,836,313
-59,540
-1% -$403K ﹤0.01% 2579
2021
Q3
$25.9M Sell
4,895,853
-90,369
-2% -$479K ﹤0.01% 2703
2021
Q2
$28.7M Sell
4,986,222
-600,073
-11% -$3.45M ﹤0.01% 2654
2021
Q1
$25.8M Sell
5,586,295
-184,784
-3% -$852K ﹤0.01% 2653
2020
Q4
$19.3M Buy
5,771,079
+822,923
+17% +$2.75M ﹤0.01% 2647
2020
Q3
$14.7M Sell
4,948,156
-142,204
-3% -$422K ﹤0.01% 2595
2020
Q2
$23.5M Sell
5,090,360
-53,756
-1% -$248K ﹤0.01% 2344
2020
Q1
$19.8M Buy
5,144,116
+337,702
+7% +$1.3M ﹤0.01% 2288
2019
Q4
$18M Sell
4,806,414
-72,934
-1% -$274K ﹤0.01% 2580
2019
Q3
$25.9M Buy
4,879,348
+17,620
+0.4% +$93.6K ﹤0.01% 2353
2019
Q2
$18.7M Buy
4,861,728
+95,933
+2% +$368K ﹤0.01% 2537
2019
Q1
$24.3M Sell
4,765,795
-63,777
-1% -$325K ﹤0.01% 2414
2018
Q4
$9.27M Buy
4,829,572
+371,421
+8% +$713K ﹤0.01% 2804
2018
Q3
$16.9M Buy
4,458,151
+185,017
+4% +$699K ﹤0.01% 2659
2018
Q2
$13.3M Buy
4,273,134
+295,227
+7% +$921K ﹤0.01% 2753
2018
Q1
$9.51M Buy
3,977,907
+336,612
+9% +$804K ﹤0.01% 2849
2017
Q4
$14.2M Buy
3,641,295
+602,872
+20% +$2.36M ﹤0.01% 2660
2017
Q3
$7.66M Sell
3,038,423
-310,126
-9% -$782K ﹤0.01% 2944
2017
Q2
$9.24M Buy
3,348,549
+340,614
+11% +$940K ﹤0.01% 2818
2017
Q1
$5.87M Buy
3,007,935
+15,600
+0.5% +$30.4K ﹤0.01% 2999
2016
Q4
$3.14M Buy
2,992,335
+82,751
+3% +$86.9K ﹤0.01% 3207
2016
Q3
$3.17M Hold
2,909,584
﹤0.01% 3211
2016
Q2
$2.07M Sell
2,909,584
-214,856
-7% -$153K ﹤0.01% 3370
2016
Q1
$3.66M Buy
3,124,440
+527,611
+20% +$617K ﹤0.01% 3124
2015
Q4
$6.36M Buy
2,596,829
+65,951
+3% +$162K ﹤0.01% 2876
2015
Q3
$7.59M Buy
2,530,878
+133,740
+6% +$401K ﹤0.01% 2753
2015
Q2
$9.9M Buy
2,397,138
+168,549
+8% +$696K ﹤0.01% 2678
2015
Q1
$9.65M Buy
2,228,589
+280,740
+14% +$1.22M ﹤0.01% 2665
2014
Q4
$5.79M Buy
1,947,849
+72,400
+4% +$215K ﹤0.01% 2819
2014
Q3
$6.23M Buy
1,875,449
+86,807
+5% +$288K ﹤0.01% 2719
2014
Q2
$4.53M Buy
1,788,642
+153,782
+9% +$389K ﹤0.01% 2886
2014
Q1
$3.7M Buy
1,634,860
+200,742
+14% +$454K ﹤0.01% 2973
2013
Q4
$2.8M Buy
1,434,118
+239,800
+20% +$468K ﹤0.01% 3056
2013
Q3
$3.64M Buy
1,194,318
+638,733
+115% +$1.95M ﹤0.01% 2899
2013
Q2
$494K Buy
+555,585
New +$494K ﹤0.01% 3484